Bonus Biogroup Is A Clinical Stage Biotechnology Company Based In Haifaisraelfounded In 2008The Company Specializes In Regenerative Medicinefocusing On Developing Therapies For Tissue Damageinflammationand Immune Related Conditionsits Mission Is To Provide Safeeffectiveand Affordable Treatments For Severe Conditions In Markets With Limited Options The Companyae S Core Technologies Include Tissue Engineering And Cell Therapybonofilla Cits Lead Productis A Tissue Engineered Bone Graft Currently In Phase Ii Iii Clinical Trials For Bone Regenerationmesencurea Cits Flagship Cell Therapytargets Severe Inflammatory Conditions And Is In Global Phase Iii Trialsbonus Biogroup Aims To Empower Patients Through Scientific Innovationintegrating Proprietary Cell Expansion And Biomaterial Expertise To Advance Its Therapeutic Offeringsthe Company Operates Within Israelae S Biotechnology Ecosystem And Is Publicly Traded On The Tel Aviv Stock Exchange
